drugset

drugset / Trial / NCT00630942

Minocycline in Primary Sclerosing Cholangitis (PSC)

NCT00630942 ↗

Phase 1 Completed 16 enrolled Mayo Clinic

NaSingle-groupTreatment

Summary

The purpose of the study is to see how safe and effective minocycline is in the treatment of Primary Sclerosing Cholangitis (PSC).

Timeline

Start: 2003-02
Primary completion: 2007-05
Completion: 2007-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Minocycline	Small molecule	100 mg	—

Indications